New target identified for preventing bone destruction, such as in arthritis, cancer
Thursday, December 5, 2013 - 13:30
in Health & Medicine
A new paper published announces the characterization of a new potent and selective PI3Kdelta inhibitor, GS-9820. The discovery suggests that selective inhibition of PI3K isoforms offers a new approach for the treatment of inflammatory bone diseases and skeletal metastases.